J. Hardenberg

541 total citations
11 papers, 458 citations indexed

About

J. Hardenberg is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, J. Hardenberg has authored 11 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 3 papers in Pharmacology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in J. Hardenberg's work include Epilepsy research and treatment (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Biochemical effects in animals (2 papers). J. Hardenberg is often cited by papers focused on Epilepsy research and treatment (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Biochemical effects in animals (2 papers). J. Hardenberg collaborates with scholars based in Sweden, France and Mexico. J. Hardenberg's co-authors include Paul J. Schechter, Norman Huebert, M Pestre, M. Guyot, Guy P. E. Tell, P Loiseau, Emilio Perucca, Carlo Andrea Galimberti, A Tártara and Raffaele Manni and has published in prestigious journals such as Journal of Neurochemistry, European Journal of Pharmacology and Epilepsia.

In The Last Decade

J. Hardenberg

11 papers receiving 424 citations

Peers

Countries citing papers authored by J. Hardenberg

Since Specialization

Citations

This map shows the geographic impact of J. Hardenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Hardenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Hardenberg more than expected).

Fields of papers citing papers by J. Hardenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Hardenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Hardenberg. The network helps show where J. Hardenberg may publish in the future.

Co-authorship network of co-authors of J. Hardenberg

This figure shows the co-authorship network connecting the top 25 collaborators of J. Hardenberg. A scholar is included among the top collaborators of J. Hardenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Hardenberg. J. Hardenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	1477. A Randomized Phase 2 Study of Cefepime Combined with the Novel Extended Spectrum β-Lactamase Inhibitor Enmetazobactam in Hospitalized Adults with Complicated Urinary Tract Infections (cUTI) Including Acute Pyelonephritis (AP) 2019 ·Open Forum Infectious Diseases ·Yehuda Carmeli, Philipp Knechtle, J. Hardenberg, Mathias Knecht	3
2	Acute Antiemetic Efficacy and Safety of Dolasetron Mesylate, A 5-HT3 Antagonist, in Cancer Patients Treated with Cisplatin 1994 ·American Journal of Clinical Oncology ·Thierry Conroy, P Cappelaere, Michel Fabbro, A. A. Fauser, T. A. W. Splinter, M. Spielmann, Martina Schneider, B Chevallier, A Goupil, J Chauvergne, P. Fargeot, (unknown), Paul O’Grady, (unknown), J. Hardenberg, Malcolm Boyce	36
3	Pharmacodynamics of MDL 72974A: absence of effect on the pressor response to oral tyramine 1994 ·PubMed ·Christian Hinze, (unknown), J. Hardenberg	3
4	A double-blind, placebo-controlled study of the tolerability and effects on platelet MAO-B activity of single oral doses of MDL 72.974A in normal volunteers 1990 ·PubMed ·Christian Hinze, (unknown), Monique Zreika, (unknown), J. Hardenberg	5
5	A double-blind, placebo-controlled study of the tolerability and effects on platelet MAO-B activity of single oral doses of MDL 72,974A in normal volunteers 1990 ·European Journal of Pharmacology ·(unknown), Christian Hinze, (unknown), J. Hardenberg, Monique Zreika	5
6	The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients. 1989 ·British Journal of Clinical Pharmacology ·E. Ben‐Menachem, (unknown), (unknown), (unknown), Norman Huebert, J. Hardenberg, L Dahlgren, J. P. Mumford	75
7	Cerebrospinal Fluid Parameters in Healthy Volunteers During Serial Lumbar Punctures 1989 ·Journal of Neurochemistry ·(unknown), Lennart Persson, Paul J. Schechter, Klaus D. Haegele, Norman Huebert, J. Hardenberg	30
8	Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy 1988 ·Epilepsy Research ·(unknown), Lennart Persson, Paul J. Schechter, Klaus D. Haegele, Norman Huebert, J. Hardenberg, (unknown), John Mumford	61
9	A Controlled Study of Oral Vigabatrin (ɣ-Vinyl GABA) in Patients with Cerebellar Ataxia 1986 ·Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ·A. M. Bonnet, (unknown), (unknown), Paul J. Schechter, J. Hardenberg, Yves Agid	11
10	Double‐Blind, Placebo‐Controlled Study of Vigabatrin (Gamma‐Vinyl GABA) in Drug‐Resistant Epilepsy 1986 ·Epilepsia ·P Loiseau, J. Hardenberg, M Pestre, M. Guyot, Paul J. Schechter, Guy P. E. Tell	122
11	Vigabatrin in the Treatment of Epilepsy: A Double‐Blind, Placebo‐Controlled Study 1986 ·Epilepsia ·A Tártara, Raffaele Manni, Carlo Andrea Galimberti, J. Hardenberg, (unknown), Emilio Perucca	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact